Page last updated: 2024-08-24

esmolol and Abnormality, Heart

esmolol has been researched along with Abnormality, Heart in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (75.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furck, A; Jivanji, SG; Slavik, Z	1
Desai, A; Furck, AK; Macrae, DJ; Slavik, Z	1
Fukushima, N; Kadoba, K; Kume, Y; Matsuda, H; Miyagawa, S; Shimazaki, Y	1
Borowski, A; Korb, H	2
Garner, SS; Sade, RM; Uber, WE; Wiest, DB	1
Borowski, A; Eichstaedt, HC; Korb, H; Raji, MR; Schickendantz, S	1
Buheitel, G; Hofbeck, M; Leipold, G; Singer, H	1

Trials

2 trial(s) available for esmolol and Abnormality, Heart

Article	Year
Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion (PVC-CONTHY-CAP) in combination with ultra-short beta-blockade and nitroglycerine. The Thoracic and cardiovascular surgeon, 1997, Volume: 45, Issue:2 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cardiopulmonary Bypass; Child; Child, Preschool; Combined Modality Therapy; Coronary Artery Bypass; Emergencies; Heart Defects, Congenital; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Length of Stay; Middle Aged; Nitroglycerin; Propanolamines; Reproducibility of Results; Time Factors; Vasodilator Agents	1997
Esmolol for the management of pediatric hypertension after cardiac operations. The Journal of thoracic and cardiovascular surgery, 1998, Volume: 115, Issue:4 Topics: Adrenergic beta-Antagonists; Aortic Coarctation; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Hypertension; Infant; Male; Postoperative Complications; Propanolamines	1998

Article

Year

Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion (PVC-CONTHY-CAP) in combination with ultra-short beta-blockade and nitroglycerine.

The Thoracic and cardiovascular surgeon, 1997, Volume: 45, Issue:2

Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cardiopulmonary Bypass; Child; Child, Preschool; Combined Modality Therapy; Coronary Artery Bypass; Emergencies; Heart Defects, Congenital; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Length of Stay; Middle Aged; Nitroglycerin; Propanolamines; Reproducibility of Results; Time Factors; Vasodilator Agents

1997

Esmolol for the management of pediatric hypertension after cardiac operations.

The Journal of thoracic and cardiovascular surgery, 1998, Volume: 115, Issue:4

Topics: Adrenergic beta-Antagonists; Aortic Coarctation; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Hypertension; Infant; Male; Postoperative Complications; Propanolamines

1998

Other Studies

6 other study(ies) available for esmolol and Abnormality, Heart

Article	Year
β-blockers in postoperative myocardial diastolic dysfunction: not a panacea. BMJ case reports, 2014, Oct-03, Volume: 2014 Topics: Adrenergic beta-Antagonists; Diastole; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Postoperative Complications; Propanolamines; Ventricular Dysfunction, Left	2014
Novel postoperative use of beta-blocking medication for infants with left ventricular outflow obstruction and diastolic myocardial dysfunction. Pediatric cardiology, 2012, Volume: 33, Issue:8 Topics: Adrenergic beta-1 Receptor Antagonists; Diastole; Echocardiography, Doppler; Heart Defects, Congenital; Heart Rate; Humans; Infant; Infant, Newborn; Infant, Premature; Propanolamines; Tachycardia; Ventilator Weaning; Ventricular Outflow Obstruction	2012
[Repair of total anomalous pulmonary venous return using an ultra-short acting beta blockade (esmolol)--case reports]. [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1996, Volume: 44, Issue:9 Topics: Adrenergic beta-Antagonists; Cardiopulmonary Bypass; Heart Defects, Congenital; Humans; Infant; Male; Propanolamines; Pulmonary Veins; Spleen	1996
Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol. A word of caution. The Thoracic and cardiovascular surgeon, 1998, Volume: 46, Issue:2 Topics: Adrenergic beta-Antagonists; Blood; Coronary Artery Bypass; Heart Defects, Congenital; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Myocardial Infarction; Myocardial Reperfusion; Postoperative Complications; Propanolamines; Treatment Outcome	1998
Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion in combination with Esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1998, Volume: 14, Issue:3 Topics: Adolescent; Adrenergic beta-Antagonists; Cardiopulmonary Bypass; Child; Child, Preschool; Coronary Vessels; Drug Therapy, Combination; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Infusions, Intra-Arterial; Myocardial Reperfusion; Nitroglycerin; Postoperative Complications; Propanolamines; Retrospective Studies; Risk Factors; Treatment Outcome; Vasodilator Agents	1998
[Incidence and treatment of reactive infundibular obstruction after balloon dilatation of critical pulmonary valve stenoses]. Zeitschrift fur Kardiologie, 1999, Volume: 88, Issue:5 Topics: Angiography; Catheterization; Echocardiography; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Propanolamines; Propranolol; Pulmonary Subvalvular Stenosis; Pulmonary Valve Stenosis	1999